UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

2021 Update on allogeneic hematopoietic stem cell transplant for myelofibrosis: A review of current data and applications on risk stratification and management

American journal of hematology, 2021-11, Vol.96 (11), p.1532-1538

2021

Volltextzugriff (PDF)

2024 update on allogeneic hematopoietic stem cell transplant for myelofibrosis: A review of current data and applications on risk stratification and management

American journal of hematology, 2024-05, Vol.99 (5), p.938-945

2024

Volltextzugriff (PDF)

Mirikizumab: A promising breakthrough in Crohn's disease treatment

Health science reports, 2024-08, Vol.7 (8), p.e2294-n/a

2024

Volltextzugriff (PDF)

Investigating the impact of prior COVID‐19 on IgG antibody and interferon γ responses after BBIBP‐CorV vaccination in a disease endemic population: A prospective observational study

Health science reports, 2023-09, Vol.6 (9), p.e1521-e1521

2023

Volltextzugriff (PDF)

Use of monoclonal antibody therapy in hematologic patients with mild‐to‐moderate COVID‐19: A retrospective single‐center experience

Cancer medicine (Malden, MA), 2023-05, Vol.12 (10), p.11248-11253

2023

Volltextzugriff (PDF)

Empirical and numerical analysis of damage tolerance in multifunctional hybrid sandwich fiber reinforced polymers composite structures for aerospace applications using compression after impact ( CAI ) testing

Polymer composites, 2024-07

2024

Volltextzugriff (PDF)

Latest FDA‐approved drug nirsevimab‐alip (Beyfortus): A gamechanger for treatment of respiratory syncytial virus

Journal of medical virology, 2023-10, Vol.95 (10), p.e29169-n/a

2023

Volltextzugriff (PDF)

Extramedullary disease relapse and progression after blinatumomab therapy for treatment of acute lymphoblastic leukemia

Cancer, 2022-02, Vol.128 (3), p.529-535

2022

Volltextzugriff (PDF)

Association of leukemia genetics with response to venetoclax and hypomethylating agents in relapsed/refractory acute myeloid leukemia

American journal of hematology, 2019-10, Vol.94 (10), p.E253-E255

2019

Volltextzugriff (PDF)

Therapy‐related acute lymphoblastic leukaemia in women with antecedent breast cancer

British journal of haematology, 2024-07, Vol.205 (1), p.158-165

2024

Volltextzugriff (PDF)

Refractory primary autoimmune myelofibrosis treated with ruxolitinib

American journal of hematology, 2021-08, Vol.96 (8), p.E283-E285

2021

Volltextzugriff (PDF)

Incorporating anatomical imaging into undergraduate anatomy labs

The FASEB journal, 2011-04, Vol.25, p.497.3-497.3

2011

Volltextzugriff (PDF)

Tyrosine kinase inhibitor maintenance following chimeric antigen receptor T‐cell therapy in Philadelphia chromosome‐positive acute lymphoblastic leukaemia

British journal of haematology, 2024-08, Vol.205 (2), p.711-715

2024

Volltextzugriff (PDF)

Venetoclax and hypomethylating agents in FLT3‐mutated acute myeloid leukemia

American journal of hematology, 2020-10, Vol.95 (10), p.1193-1199

2020

Volltextzugriff (PDF)

Venetoclax and hypomethylating agents yield high response rates and favourable transplant outcomes in patients with newly diagnosed acute myeloid leukaemia

British journal of haematology, 2022-03, Vol.196 (6), p.e71-e74

2022

Volltextzugriff (PDF)

High prevalence and inferior long‐term outcomes for TP53 mutations in therapy‐related acute lymphoblastic leukemia

American journal of hematology, 2022-05, Vol.97 (5), p.E171-E173

2022

Volltextzugriff (PDF)

Toxicities associated with tyrosine kinase inhibitor maintenance following allogeneic hematopoietic cell transplantation in Philadelphia chromosome‐positive acute lymphoblastic leukemia

American journal of hematology, 2024-09, Vol.99 (9), p.1680-1690

2024

Volltextzugriff (PDF)

Outcome of secondary acute myeloid leukemia treated with hypomethylating agent plus venetoclax (HMA‐Ven) or liposomal daunorubicin‐cytarabine (CPX‐351)

American journal of hematology, 2021-06, Vol.96 (6), p.E196-E200

2021

Volltextzugriff (PDF)

Quality of MCQ‐based exams: why functioning distractors matter (533.4)

The FASEB journal, 2014-04, Vol.28 (S1), p.n/a

Ali, Syed Haris

2014

Volltextzugriff (PDF)

Effect of repeated exercise fatigue on the swimming performance of juvenile rock carp (Procypris rabaudi, Tchang)

Journal of applied ichthyology, 2020-12, Vol.36 (6), p.811-816

2020

Volltextzugriff (PDF)

Philadelphia chromosome as a recurrent event among therapy‐related acute leukemia

American journal of hematology, 2017-02, Vol.92 (2), p.E18-E19

2017

Volltextzugriff (PDF)

Refractory primary autoimmune myelofibrosis treated with ruxolitinib

American journal of hematology, 2021, Vol.96 (8), p.E283-E285

2021

Volltextzugriff (PDF)

Corporate social responsibility and employee performance: The mediating role of employee engagement in the manufacturing sector of Pakistan

Corporate social-responsibility and environmental management, 2020-11, Vol.27 (6), p.2908-2919

2020

Volltextzugriff (PDF)

S3553 Malignant Transformation of a Gastric Duplication Cyst: A Rare Entity

The American journal of gastroenterology, 2022-10, Vol.117 (10S), p.e2231-e2232

2022

Volltextzugriff (PDF)

1 – 25 von 52

Suche als RSS-Feed

Aktive Filter

KollektionWiley Online Library

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(51)
Mit Volltextzugriff
(50)

Publikationsform

Sprache

Englisch
(52)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(44)
Life Sciences & Biomedicine
(32)
Hematology
(14)
Technology
(12)
Humans
(11)
Patients
(7)
Acute Lymphoblastic Leukemia
(6)
Leukemia
(6)
Engineering
(5)
Hematopoietic Stem Cells
(5)
Physical Sciences
(5)
Retrospective Studies
(5)
Accuracy
(4)
Acute Myeloid Leukemia
(4)
Allografts
(4)
Covid-19
(4)
Engineering, Electrical & Electronic
(4)
Lymphatic Leukemia
(4)
Philadelphia Chromosome
(4)
Transplants & Implants
(4)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

2021 Update on allogeneic hematopoietic stem cell transplant for myelofibrosis: A review of current data and applications on risk stratification and management

2024 update on allogeneic hematopoietic stem cell transplant for myelofibrosis: A review of current data and applications on risk stratification and management

Mirikizumab: A promising breakthrough in Crohn's disease treatment

Investigating the impact of prior COVID‐19 on IgG antibody and interferon γ responses after BBIBP‐CorV vaccination in a disease endemic population: A prospective observational study

Use of monoclonal antibody therapy in hematologic patients with mild‐to‐moderate COVID‐19: A retrospective single‐center experience

Empirical and numerical analysis of damage tolerance in multifunctional hybrid sandwich fiber reinforced polymers composite structures for aerospace applications using compression after impact ( CAI ) testing

Latest FDA‐approved drug nirsevimab‐alip (Beyfortus): A gamechanger for treatment of respiratory syncytial virus

Extramedullary disease relapse and progression after blinatumomab therapy for treatment of acute lymphoblastic leukemia

Association of leukemia genetics with response to venetoclax and hypomethylating agents in relapsed/refractory acute myeloid leukemia

Therapy‐related acute lymphoblastic leukaemia in women with antecedent breast cancer

Refractory primary autoimmune myelofibrosis treated with ruxolitinib

Incorporating anatomical imaging into undergraduate anatomy labs

Tyrosine kinase inhibitor maintenance following chimeric antigen receptor T‐cell therapy in Philadelphia chromosome‐positive acute lymphoblastic leukaemia

Venetoclax and hypomethylating agents in FLT3‐mutated acute myeloid leukemia

Venetoclax and hypomethylating agents yield high response rates and favourable transplant outcomes in patients with newly diagnosed acute myeloid leukaemia

High prevalence and inferior long‐term outcomes for TP53 mutations in therapy‐related acute lymphoblastic leukemia

Toxicities associated with tyrosine kinase inhibitor maintenance following allogeneic hematopoietic cell transplantation in Philadelphia chromosome‐positive acute lymphoblastic leukemia

Outcome of secondary acute myeloid leukemia treated with hypomethylating agent plus venetoclax (HMA‐Ven) or liposomal daunorubicin‐cytarabine (CPX‐351)

High response rates and transition to transplant after novel targeted and cellular therapies in adults with relapsed/refractory acute lymphoblastic leukemia with Philadelphia‐like fusions

Quality of MCQ‐based exams: why functioning distractors matter (533.4)

Effect of repeated exercise fatigue on the swimming performance of juvenile rock carp (Procypris rabaudi, Tchang)

Philadelphia chromosome as a recurrent event among therapy‐related acute leukemia

Refractory primary autoimmune myelofibrosis treated with ruxolitinib

Corporate social responsibility and employee performance: The mediating role of employee engagement in the manufacturing sector of Pakistan

S3553 Malignant Transformation of a Gastric Duplication Cyst: A Rare Entity

Aktive Filter

Suchergebnisse filtern